Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schraml

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Praxis|June 26, 2004
[Oncogenes--motors of the cancer cell]P Schraml
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Tissue banks for molecular diagnostics]P Schraml
Cancer Research|September 1, 1997
Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinomaP Schraml, I Bendik, C U Ludwig
Journal of Receptor and Signal Transduction Research|March 11, 1999
Simple and fast method to test the receptor for advanced glycosylated endproducts (RAGE) for its tumor suppressive potential using the Tet-On systemI Bendik, P Schraml, C U Ludwig
Cancer Research|March 4, 1998
Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancerI Bendik, P Schraml, C U Ludwig
Lung Cancer (Amsterdam, Netherlands)|April 3, 2001
A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancerS Schenk, P Schraml, I Bendik, et al.
International Journal of Oncology|February 10, 1998
Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinomaR Shipman, P Schraml, M Colombi, et al.
Trends in Genetics : TIG|March 1, 1993
cDNA subtraction library construction using a magnet-assisted subtraction technique (MAST)P Schraml, R Shipman, P Stulz, et al.
Cancer Research|October 1, 1994
Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissueP Schraml, R Shipman, M Colombi, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|November 27, 2007
[Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer]M Oeggerli, P Schraml, H Novotny, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Praxis|June 26, 2004
[Oncogenes--motors of the cancer cell]P Schraml
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Tissue banks for molecular diagnostics]P Schraml
Cancer Research|September 1, 1997
Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinomaP Schraml, I Bendik, C U Ludwig
Journal of Receptor and Signal Transduction Research|March 11, 1999
Simple and fast method to test the receptor for advanced glycosylated endproducts (RAGE) for its tumor suppressive potential using the Tet-On systemI Bendik, P Schraml, C U Ludwig
Cancer Research|March 4, 1998
Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancerI Bendik, P Schraml, C U Ludwig
Lung Cancer (Amsterdam, Netherlands)|April 3, 2001
A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancerS Schenk, P Schraml, I Bendik, et al.
International Journal of Oncology|February 10, 1998
Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinomaR Shipman, P Schraml, M Colombi, et al.
Trends in Genetics : TIG|March 1, 1993
cDNA subtraction library construction using a magnet-assisted subtraction technique (MAST)P Schraml, R Shipman, P Stulz, et al.
Cancer Research|October 1, 1994
Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissueP Schraml, R Shipman, M Colombi, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|November 27, 2007
[Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer]M Oeggerli, P Schraml, H Novotny, et al.
Pageof 6